Search Results - David Meya
- Showing 1 - 15 results of 15
-
1
-
2
-
3
Longitudinal Changes in CD4<sup>+</sup>, CD8<sup>+</sup> T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococ... by Alice Bayiyana, Samuel Okurut, Rose Nabatanzi, Godfrey Zziwa, David R. Boulware, Fredrick Lutwama, David Meya
Published 2019-07-01
Article -
4
-
5
-
6
Pathways to care with HIV-associated cryptococcal meningitis in Botswana and Uganda: Findings from a qualitative methods study by David S. Lawrence, Agnes Ssali, Neo Moshashane, Georgina Nabaggala, Lebogang Maphane, Thomas S. Harrison, David Meya, Joseph N. Jarvis, Janet Seeley
Published 2023-12-01
Article -
7
-
8
Poor long-term outcomes despite improved hospital survival for patients with cryptococcal meningitis in rural, Northern Uganda. by Mark Okwir, Abigail Link, Bosco Opio, Fred Okello, Ritah Nakato, Betty Nabongo, Jimmy Alal, Joshua Rhein, David Meya, Yu Liu, Paul R Bohjanen
Published 2024-01-01
Article -
9
Poor long-term outcomes despite improved hospital survival for patients with cryptococcal meningitis in rural, Northern Uganda by Mark Okwir, Abigail Link, Bosco Opio, Fred Okello, Ritah Nakato, Betty Nabongo, Jimmy Alal, Joshua Rhein, David Meya, Yu Liu, Paul R. Bohjanen
Published 2024-01-01
Article -
10
-
11
Health-related quality of life and hypertension in people with HIV on long-term antiretroviral therapy in Uganda. by Charles Batte, Andrew Weil Semulimi, John Mukisa, Mariam Nakabuye, Jasper Nidoi, David Mukunya, Rosalind Parkes Ratanshi, Barbara Castelnuovo, Mohammed Lamorde, David Meya, William Checkley, Robert Kalyesubula, Trishul Siddharthan, Joseph B Babigumira
Published 2024-01-01
Article -
12
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study) [version 1; re... by Fiona V. Cresswell, Kenneth Ssebambulidde, Daniel Grint, Lindsey te Brake, Abdul Musabire, Rachel R. Atherton, Lillian Tugume, Conrad Muzoora, Robert Lukande, Mohammed Lamorde, Rob Aarnoutse, David Meya, David R. Boulware, Alison M. Elliott
Published 2018-07-01
Article -
13
Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population. by Shevin T Jacob, Christopher C Moore, Patrick Banura, Relana Pinkerton, David Meya, Pius Opendi, Steven J Reynolds, Nathan Kenya-Mugisha, Harriet Mayanja-Kizza, W Michael Scheld, Promoting Resource-Limited Interventions for Sepsis Management in Uganda (PRISM-U) Study Group
Published 2009-11-01
Article -
14
Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial [version 2; peer r... by Tadeo Kiiza Kandole, Michael Okirwoth, Thomas S. Harrison, Fiona Cresswel, Katherine Fielding, David Moore, David Boulware, David Meya, Joseph N. Jarvis, Jayne Ellis, Enock Kagimu, Laura Nsangi, Gila Hale, Ananta Bangdiwala, Timothy Mugabi, Jane Gakuru, Asmus Tukundane, Enos Kigozi
Published 2024-06-01
Article -
15
Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial by Pauline Byakika-Kibwika, Christine Sekaggya-Wiltshire, Jerome Roy Semakula, Jane Nakibuuka, Joseph Musaazi, James Kayima, Cornelius Sendagire, David Meya, Bruce Kirenga, Sarah Nanzigu, Arthur Kwizera, Fred Nakwagala, Ivan Kisuule, Misaki Wayengera, Henry G. Mwebesa, Moses R. Kamya, William Bazeyo
Published 2021-12-01
Article